Ensuring timely reauthorization of PDUFA and BsUFA

Today, the House Energy and Commerce Subcommittee on Health will be hosting a markup session on the comprehensive legislative package to reauthorize the human drug user fee programs, including the...
Read More
ICYMI: PhRMA COO Lori Reilly spotlights efforts to improve health care in 2022 and beyond

The COVID-19 pandemic has made clear how important a stable health care system is to the American people, both during times of crisis and beyond. Patients deserve sustainable, patient-centered...
Read More
During the pandemic, about four in 10 American adults have reported symptoms of anxiety or depressive disorder. This share is up from one in 10 adults reporting symptoms prior to the pandemic....
Read More
ICYMI: New resource catalogs biopharmaceutical industry lessons learned from COVID-19

Since the start of the pandemic, America’s biopharmaceutical companies have worked around the clock to research, develop and manufacture treatments and vaccines to fight COVID-19. We’ve made...
Read More
The biopharmaceutical industry leads in helping women achieve new heights, according to IAM’s diversity 100

“Phenomenal pharma” – that’s how a recent report by IAM described the biopharmaceutical industry’s leadership in inventor diversity. The report accompanied the release of IAM’s Diversity 100 list,...
Read More
Report: More than 600 medicines in development for diseases affecting women

As we approach the end of celebrating Women’s History Month, we’re taking a closer look at the biopharmaceutical progress made and challenges to be addressed for women’s health.
Read More
The accelerated approval pathway: Helping patients with serious or life-threatening diseases

Today, the House Energy & Commerce Committee’s Subcommittee on Health will meet to discuss policy proposals to “encourage innovation and improve oversight” regarding medical innovation. This hearing...
Read More
Biopharmaceutical industry drives economic growth in all 50 states

The innovative biopharmaceutical industry has long been a significant driver of the nation’s economic growth and a key contributor to state and regional economies. A new report from TEConomy Partners...
Read More
Biopharmaceutical research and development has ushered in a decade of innovation in rare disease

This year on Rare Disease Day, we join families and communities around the world building awareness around rare diseases and encouraging patients to share their stories.
Read More
4 things to know about biopharmaceutical efforts to fight cancer

A recent study published in Nature is a profound reminder of how far we’ve come in the fight against cancer. Authors of the study, which examined the long-term effects of CAR-T cell therapy,...
Read More